The first case of Philadelphia chromosome-negative acute promyelocytic leukemia following imatinib for chronic myelogenous leukemia

被引:3
作者
Wakim, Jad J. [1 ]
Tirado, Carlos A. [2 ]
Dowell, Jonathan [1 ,3 ]
Chen, Weina [4 ]
机构
[1] Univ Texas SW Med Ctr Dallas, Div Hematol & Oncol, Dallas, TX 75390 USA
[2] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA
[3] N Texas Healthcare Syst, Dallas, TX USA
[4] Ameripath Quest Diagnost, Dallas, TX USA
关键词
Chronic myeloid leukemia; chromosomal abnormalities; Philadelphia chromosome-negative; acute promyelocytic leukemia; imatinib; CHRONIC MYELOID-LEUKEMIA; MESYLATE THERAPY; DISEASE; ABNORMALITIES; MECHANISMS; BIOLOGY; CML;
D O I
10.1016/j.cancergen.2012.01.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In chronic myelogenous leukemia, chromosomal abnormalities in Philadelphia-negative cells are rare and usually transient, but can infrequently lead to myelodysplastic syndrome and/or acute myeloid leukemia. We report an 82-ear-old patient with an 11-year history of chronic myelogenous leukemia, in complete cytogenetic response, who developed Philadelphia-negative t(15;17)/PMLRARA acute promyelocytic leukemia. This isolated case reaffirms several important clinicopathologic and biologic aspects of chronic myelogenous leukemia, and sheds a unique light on its Philadelphia-negative hematopoiesis. It also underlines the importance of continued cytogenetic monitoring of patients in complete cytogenetic response for the emergence of new chromosomal abnormalities.
引用
收藏
页码:124 / 127
页数:4
相关论文
共 13 条
[1]   The presence of typical and atypical BCR-ABL fusion genes in leukocytes of normal individuals: Biologic significance and implications for the assessment of minimal residual disease [J].
Bose, S ;
Deininger, M ;
Gora-Tybor, J ;
Goldman, JM ;
Melo, JV .
BLOOD, 1998, 92 (09) :3362-3367
[2]   Emergence of clonal cytogenetic abnormalities in Ph- cells in some CML patients in cytogenetic remission to imatinib but restoration of polyclonal hematopoiesis in the majority [J].
Bumm, T ;
Müller, C ;
Al-Ali, HK ;
Krohn, K ;
Shepherd, P ;
Schmidt, E ;
Leiblein, S ;
Franke, C ;
Hennig, E ;
Friedrich, T ;
Krahl, R ;
Niederwieser, D ;
Deininger, MWN .
BLOOD, 2003, 101 (05) :1941-1949
[3]   Mechanisms of disease - The biology of chronic myeloid leukemia [J].
Faderl, S ;
Talpaz, M ;
Estrov, Z ;
O'Brien, S ;
Kurzrock, R ;
Kantarjian, HM .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (03) :164-172
[4]   Mechanisms of disease - Chronic myeloid leukemia - Advances in biology and new approaches to treatment [J].
Goldman, JM ;
Melo, JV .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (15) :1451-1464
[5]  
Gong JG, 1999, NATURE, V399, P806
[6]   Chromosomal abnormalities in Philadelphia chromosome-negative metaphases appearing during imatinib mesylate therapy in patients with newly diagnosed chronic myeloid leukemia in chronic phase [J].
Jabbour, Elias ;
Kantarjian, Hagop M. ;
Abruzzo, Lynne V. ;
O'Brien, Susan ;
Garcia-Manero, Guillermo ;
Verstovsek, Srdan ;
Shan, Jianqin ;
Rios, Mary Beth ;
Cortes, Jorge .
BLOOD, 2007, 110 (08) :2991-2995
[7]  
KANTARJIAN HM, 1988, CANCER-AM CANCER SOC, V61, P1441, DOI 10.1002/1097-0142(19880401)61:7<1441::AID-CNCR2820610727>3.0.CO
[8]  
2-C
[9]   Myelodysplastic syndromes and acute leukemia developing after imatinib mesylate therapy for chronic myeloid leukemia [J].
Kovitz, Craig ;
Kantarjian, Hagop ;
Garcia-Manero, Guillermo ;
Abruzzo, Lynne V. ;
Cortes, Jorge .
BLOOD, 2006, 108 (08) :2811-2813
[10]   Development of AML with t(8;21)(q22;q22) and RUNX1-RUNX1T1 fusion following Philadelphia-negative clonal evolution during treatment of CML with Imatinib [J].
Schafhausen, Philippe ;
Dierlamm, Judith ;
Bokemeyer, Carsten ;
Bruemmendorf, Tim H. ;
Bacher, Ulrike ;
Zander, Axel R. ;
Schnittger, Susanne ;
Hochhaus, Andreas .
CANCER GENETICS AND CYTOGENETICS, 2009, 189 (01) :63-67